Constance Therapeutics Stock
A vertically integrated medicinal cannabis company.
Sign up today and learn more about Constance Therapeutics Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Constance Therapeutics Stock
Constance Therapeutics produces whole plant cannabis extracts as part of an integrative approach to treatment; this is the Constance Therapeutics difference. They provide physicians and their patients with expanded treatment options in cases where only pharmaceuticals may have been prescribed in the past.
Funding History
July 2016 | $0 |
---|---|
August 2017 | $500K |
Management
CEO
Constance Finley